- ISIN
- US98978V1035
- CUSIP
- 98978V103
- Sector
- Healthcare
- IPO Date
- Feb 1, 2013
Highlights
- Market Cap
- $33.51B
- Enterprise Value
- $31.76B
- EPS (TTM)
- $6.04
- PE Ratio
- 13.13
- PEG Ratio
- 1.47
- Total Revenue (TTM)
- $9.51B
- Gross Profit (TTM)
- $6.73B
- EBITDA (TTM)
- $3.95B
- Year Range
- $72.38 - $161.77
- Target Price
- $143.50
- ROA (TTM)
- 17.44%
- ROE (TTM)
- 81.75%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
ZTS Performance Chart
Zoetis Inc. (ZTS) is down 36.4% since the beginning of the year. At $79 per share, ZTS is trading 51.0% below its 52-week high of $162. Investors who bought $1,000 worth of ZTS shares 5 years ago would now be looking at an investment worth $448.
Loading charts...
Returns By Period
Zoetis Inc. (ZTS) has returned -36.40% so far this year and -50.99% over the past 12 months. Over the last ten years, ZTS has returned 6.38% per year, falling short of the S&P 500 Index benchmark, which averaged 13.75% annually.
Zoetis Inc.
- 1D
- -0.78%
- 1M
- 6.88%
- YTD
- -36.40%
- 6M
- -35.07%
- 1Y
- -50.99%
- 3Y*
- -21.61%
- 5Y*
- -14.85%
- 10Y*
- 6.38%
Benchmark (S&P 500 Index)
- 1D
- -0.57%
- 1M
- 1.39%
- YTD
- 9.73%
- 6M
- 10.46%
- 1Y
- 24.50%
- 3Y*
- 19.43%
- 5Y*
- 12.21%
- 10Y*
- 13.75%
ZTS Monthly Returns History
Based on dividend-adjusted daily data since Feb 1, 2013, ZTS's average daily return is +0.04%, while the average monthly return is +0.88%. At this rate, an investment would double in approximately 6.6 years.
Historically, 61% of months were positive and 39% were negative. The best month was Nov 2014 with a return of +21.4%, while the worst month was May 2026 at -32.4%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 6 months.
On a daily basis, ZTS closed higher 52% of trading days. The best single day was Mar 24, 2020 with a return of +12.0%, while the worst single day was May 7, 2026 at -21.5%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -0.37% | 5.03% | -9.83% | -2.32% | -32.43% | 2.11% | -36.40% | ||||||
| 2025 | 5.21% | -2.14% | -1.55% | -4.69% | 7.82% | -7.52% | -6.20% | 7.28% | -6.45% | -1.18% | -11.04% | -1.84% | -21.75% |
| 2024 | -4.63% | 5.60% | -14.68% | -5.62% | 6.48% | 2.24% | 4.10% | 1.92% | 6.48% | -8.28% | -1.97% | -7.03% | -16.63% |
| 2023 | 13.19% | 0.91% | -0.34% | 5.84% | -7.26% | 5.64% | 9.46% | 1.29% | -8.68% | -9.54% | 12.53% | 11.72% | 35.91% |
| 2022 | -18.00% | -3.07% | -2.61% | -5.85% | -3.57% | 0.56% | 6.40% | -14.25% | -5.26% | 1.90% | 2.23% | -4.92% | -39.51% |
| 2021 | -6.65% | 0.64% | 1.44% | 10.04% | 2.11% | 5.48% | 8.91% | 0.92% | -5.09% | 11.50% | 2.70% | 9.90% | 48.26% |
Benchmark Metrics
Zoetis Inc. has an annualized alpha of -0.72%, beta of 0.89, and R2 of 0.32 versus S&P 500 Index. Calculated based on daily prices since February 01, 2013.
- This stock participated in 93.24% of S&P 500 Index downside but only 75.60% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.32 means the benchmark explains less than half of this stock's behavior - treat beta with caution or consider switching to a more representative benchmark.
- Alpha
- -0.72%
- Beta
- 0.89
- R²
- 0.32
- Upside Capture
- 75.60%
- Downside Capture
- 93.24%
Return for Risk
Risk / Return Rank
ZTS ranks 2 for risk / return — in the bottom 2% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Zoetis Inc. (ZTS) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ZTS | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.42 | ||
| Sortino ratioReturn per unit of downside risk | -4.73 | ||
| Omega ratioGain probability vs. loss probability | 0.67 | 1.36 | -0.69 |
| Calmar ratioReturn relative to maximum drawdown | -0.96 | 2.71 | -3.66 |
| Martin ratioReturn relative to average drawdown | -2.10 | 12.15 | -14.25 |
Dividends
Dividend History
Zoetis Inc. provided a 2.60% dividend yield over the last twelve months, with an annual payout of $2.06 per share. The company has been increasing its dividends for 12 consecutive years.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $2.06 | $2.00 | $1.73 | $1.50 | $1.30 | $1.00 | $0.80 | $0.66 | $0.50 | $0.42 | $0.38 | $0.33 |
Dividend yield | 2.60% | 1.59% | 1.06% | 0.76% | 0.89% | 0.41% | 0.48% | 0.50% | 0.59% | 0.58% | 0.71% | 0.69% |
Monthly Dividends
The table displays the monthly dividend distributions for Zoetis Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.53 | $0.00 | $0.00 | $0.53 | $0.00 | $0.00 | $1.06 | ||||||
| 2025 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $2.00 |
| 2024 | $0.43 | $0.00 | $0.00 | $0.43 | $0.00 | $0.00 | $0.43 | $0.00 | $0.00 | $0.43 | $0.00 | $0.00 | $1.73 |
| 2023 | $0.38 | $0.00 | $0.00 | $0.38 | $0.00 | $0.00 | $0.38 | $0.00 | $0.00 | $0.38 | $0.00 | $0.00 | $1.50 |
| 2022 | $0.33 | $0.00 | $0.00 | $0.33 | $0.00 | $0.00 | $0.33 | $0.00 | $0.00 | $0.33 | $0.00 | $0.00 | $1.30 |
| 2021 | $0.25 | $0.00 | $0.00 | $0.25 | $0.00 | $0.00 | $0.25 | $0.00 | $0.00 | $0.25 | $0.00 | $0.00 | $1.00 |
Dividend Yield & Payout
Dividend Yield
Zoetis Inc. has a dividend yield of 2.60%, which is quite average when compared to the overall market.
Payout Ratio
Zoetis Inc. has a payout ratio of 33.64%, which is quite average when compared to the overall market. This suggests that Zoetis Inc. strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Zoetis Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Zoetis Inc. was 68.48%, occurring on May 15, 2026. The portfolio has not yet recovered.
The current Zoetis Inc. drawdown is 66.31%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 bear market2026 | -68.48%May 2026 | 4y 4mo | — | 4y 5moDec 2021 - now |
COVID crash2020 | -36.07%Mar 2020 | 1mo 8d | 3mo 26d | 5mo 4dFeb 2020 - Jul 2020 |
2016 bear market2016 | -28.57%Feb 2016 | 7mo 19d | 11mo 22d | 1y 7moJun 2015 - Jan 2017 |
2014 correction2014 | -17.32%Apr 2014 | 1y 27d | 4mo 10d | 1y 5moMar 2013 - Aug 2014 |
2021 correction2021 | -17.28%Mar 2021 | 3mo 29d | 1mo 26d | 5mo 25dNov 2020 - Apr 2021 |
Drawdown Indicators
| ZTS | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -68.48% | -56.78% | -11.70% |
Max Drawdown (1Y)Largest decline over 1 year | -53.38% | -9.10% | -44.28% |
Max Drawdown (3Y)Largest decline over 3 years | -61.77% | -18.90% | -42.87% |
Max Drawdown (5Y)Largest decline over 5 years | -68.48% | -25.43% | -43.05% |
Max Drawdown (10Y)Largest decline over 10 years | -68.48% | -33.92% | -34.56% |
Current DrawdownCurrent decline from peak | -66.31% | -1.29% | -65.02% |
Average DrawdownAverage peak-to-trough decline | -14.88% | -10.72% | -4.16% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 25.33% | 2.02% | +23.31% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Zoetis Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Zoetis Inc. is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for ZTS, comparing it with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, ZTS has a P/E ratio of 13.1. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for ZTS compared to other companies in the Drug Manufacturers - Specialty & Generic industry. ZTS currently has a PEG ratio of 1.5. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ZTS relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, ZTS has a P/S ratio of 3.6. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ZTS in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, ZTS has a P/B value of 10.4. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with ZTS
Add Zoetis Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with ZTS